Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 119

Related Citations for PubMed (Select 19761527)

1.

Successful treatment of severe subcutaneous insulin resistance with inhaled insulin therapy.

van Alfen-van der Velden AA, Noordam C, de Galan BE, Hoorweg-Nijman JJ, Voorhoeve PG, Westerlaken C.

Pediatr Diabetes. 2010 Sep;11(6):380-2. doi: 10.1111/j.1399-5448.2009.00597.x. Epub 2009 Sep 16.

PMID:
19761527
2.

Meta-analysis: efficacy and safety of inhaled insulin therapy in adults with diabetes mellitus.

Ceglia L, Lau J, Pittas AG.

Ann Intern Med. 2006 Nov 7;145(9):665-75.

PMID:
17088580
3.

Inhaled insulin improves glycemic control when substituted for or added to oral combination therapy in type 2 diabetes: a randomized, controlled trial.

Rosenstock J, Zinman B, Murphy LJ, Clement SC, Moore P, Bowering CK, Hendler R, Lan SP, Cefalu WT.

Ann Intern Med. 2005 Oct 18;143(8):549-58.

PMID:
16230721
4.
5.

Efficacy and safety of inhaled insulin (Exubera) compared with subcutaneous insulin therapy in patients with type 1 diabetes: results of a 6-month, randomized, comparative trial.

Quattrin T, BĂ©langer A, Bohannon NJ, Schwartz SL; Exubera Phase III Study Group.

Diabetes Care. 2004 Nov;27(11):2622-7.

PMID:
15504996
6.
7.

Inhaled human insulin.

Strack TR.

Drugs Today (Barc). 2006 Apr;42(4):207-21. Review.

PMID:
16703118
8.

Patient satisfaction and glycemic control after 1 year with inhaled insulin (Exubera) in patients with type 1 or type 2 diabetes.

Rosenstock J, Cappelleri JC, Bolinder B, Gerber RA.

Diabetes Care. 2004 Jun;27(6):1318-23.

PMID:
15161782
9.

Efficacy of inhaled human insulin in type 1 diabetes mellitus: a randomised proof-of-concept study.

Skyler JS, Cefalu WT, Kourides IA, Landschulz WH, Balagtas CC, Cheng SL, Gelfand RA.

Lancet. 2001 Feb 3;357(9253):331-5.

PMID:
11210993
10.

The effect of insulin antibodies on the metabolic action of inhaled and subcutaneous insulin: a prospective randomized pharmacodynamic study.

Heise T, Bott S, Tusek C, Stephan JA, Kawabata T, Finco-Kent D, Liu C, Krasner A.

Diabetes Care. 2005 Sep;28(9):2161-9.

PMID:
16123484
11.

A breath of life for inhaled insulin: severe subcutaneous insulin resistance as an indication?

Mastrandrea LD.

Pediatr Diabetes. 2010 Sep;11(6):377-9. doi: 10.1111/j.1399-5448.2010.00713.x. No abstract available.

PMID:
20738801
12.

Exubera inhaled insulin in patients with type 1 and type 2 diabetes: the first 12 months.

Alabraba V, Farnsworth A, Leigh R, Dodson P, Gough SC, Smyth T.

Diabetes Technol Ther. 2009 Jul;11(7):427-30. doi: 10.1089/dia.2008.0131.

PMID:
19580355
13.

Inhaled insulin--does it become reality?

Siekmeier R, Scheuch G.

J Physiol Pharmacol. 2008 Dec;59 Suppl 6:81-113. Review.

14.

Efficacy and safety of inhaled insulin (exubera) compared with subcutaneous insulin therapy in patients with type 2 diabetes: results of a 6-month, randomized, comparative trial.

Hollander PA, Blonde L, Rowe R, Mehta AE, Milburn JL, Hershon KS, Chiasson JL, Levin SR.

Diabetes Care. 2004 Oct;27(10):2356-62.

PMID:
15451900
15.

Exubera: inhaled insulin for diabetes.

[No authors listed]

Drug Ther Bull. 2007 Jan;45(1):5-8. Review.

PMID:
17367046
16.

Dose-response relationships of inhaled insulin delivered via the Aerodose insulin inhaler and subcutaneously injected insulin in patients with type 2 diabetes.

Kim D, Mudaliar S, Chinnapongse S, Chu N, Boies SM, Davis T, Perera AD, Fishman RS, Shapiro DA, Henry R.

Diabetes Care. 2003 Oct;26(10):2842-7.

PMID:
14514589
17.

Intrasubject variability of inhaled insulin in type 1 diabetes: a comparison with subcutaneous insulin.

Kapitza C, Hompesch M, Scharling B, Heise T.

Diabetes Technol Ther. 2004 Aug;6(4):466-72.

PMID:
15321001
18.

Inhaled human insulin treatment in patients with type 2 diabetes mellitus.

Cefalu WT, Skyler JS, Kourides IA, Landschulz WH, Balagtas CC, Cheng S, Gelfand RA; Inhaled Insulin Study Group.

Ann Intern Med. 2001 Feb 6;134(3):203-7.

PMID:
11177333
19.

Use of inhaled insulin in a basal/bolus insulin regimen in type 1 diabetic subjects: a 6-month, randomized, comparative trial.

Skyler JS, Weinstock RS, Raskin P, Yale JF, Barrett E, Gerich JE, Gerstein HC; Inhaled Insulin Phase III Type 1 Diabetes Study Group.

Diabetes Care. 2005 Jul;28(7):1630-5.

PMID:
15983312
20.

First approved inhaled insulin therapy for diabetes mellitus.

Jani R, Triplitt C, Reasner C, Defronzo RA.

Expert Opin Drug Deliv. 2007 Jan;4(1):63-76. Review. Erratum in: Expert Opin Drug Deliv. 2007 Mar;4(2):191.

PMID:
17184163
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk